← SynDRA
SB-203580
SynDRA canonical compound SYN0000025 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MAPK11 |
| Mechanism of action | P38 MAPK inhibitor |
All known targets
- MAPK14
- MAPK11
- GAK
- MAPK1
- AKT1
- MAPK9
- SRC
- SGK1
- RPS6KB1
- ROCK1
- RIPK2
- RAF1
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- GAK INHIBITOR
- MAPK11 INHIBITOR
- PTGS2 INHIBITOR
- IL1R1 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- EGFR
- TGFBR1
- CSNK1D
- CSNK1E
- STK32A
- STK32B
- PTGS1
- STK36
- SYK
- CYP1A2
- CYP2C19
- CYP2C9
- TBXAS1
- BRAF
- MINK1
- MET
- BMPR1B
- CSNK1A1L
- CSNK1A1
- CDC42BPA
- NLK
- CHRM1
- RPS6KA1
- GCGR
- SIK2
- SIK3
- CIT
- P2RX7
- CDC42BPB
- SLK
- FRK
- FPR3
- COQ8B
- PTK6
- CDC42BPG
- ERBB4
- RPS6KA6
- ABL1
- DMPK
- EPHA6
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACV1B
- NSD2
- MK09
- MK10
- MK11
- MK12
- MK14
- MRCKG
- NTM1A
- CP1A2
- NTMT1
- SNCA
- ST32B
- SYUA
- TGFR2
- TP53
- MK08
- MK01
- M4K4
- KSYK
- KS6A6
- KS6A1
- KPCD2
- KC1E
- KC1D
- KC1A
- IFNG
- GPX4
- CTRO
- CP3A4
- CP2D6
- CP2CJ
- CP2C9
- VGFR3
Cross-references
Synonyms
- SB203580
- 4-(4-(4-fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-5-yl)pyridine
- 4-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-5-(4-pyridyl)-1H-imidazole
- CHEBI:90705
- 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole
- CHEMBL10
- RWJ 64809
- 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole
- 4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine
- PB 203580
- UNII-WS78QR6DSV
- Adezmapimod
- RefChem:884635
- DTXCID0020577
- RWJ-64809
- C21H16FN3OS
- PB-203580
- MFCD00922198
- OU13V1EYWQ
- UNII-OU13V1EYWQ
- SR-01000597367
- 1pme
- Kinome_2521
- Tocris-1202
- Tocris-1402
- ADEZMAPIMOD [INN]
- CBiol_001970
- SCHEMBL95208
- BSPBio_001104
- MLS006010840
- SCHEMBL220990
- cid_176155
- GTPL5269
- orb1307506
- BDBM13336
- EX-A134
- CDMGBJANTYXAIV-UHFFFAOYSA-N
- BDBM192501
Look up SB-203580 in the interactive SynDRA portal →